Immunotherapies for acute viral myocarditis in the pediatric patient

Pediatric Critical Care Medicine

Volumn 7, Issue 6 SUPPL., 2006, Pages

  Feltes, Timothy F ^a   Adatia, Ian ^b  

^a OHIO STATE UNIVERSITY   (United States)

^b UNIVERSITY OF SAN FRANCISCO   (United States)

Author keywords

Acute viral myocarditis; Immunosuppressive therapy; Pediatrics

Indexed keywords

AZATHIOPRINE; IMMUNOGLOBULIN; IMMUNOSUPPRESSIVE AGENT; METHYLPREDNISOLONE; OKT 3; PREDNISONE;

CONFERENCE PAPER; CONGESTIVE CARDIOMYOPATHY; DISEASE CLASSIFICATION; DISEASE MARKER; DRUG EFFICACY; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FUNCTION; HERPES ZOSTER; HUMAN; IMMUNOTHERAPY; OUTCOME ASSESSMENT; POLYMERASE CHAIN REACTION; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL RATE; THERAPY EFFECT; VIRUS GENOME; VIRUS MYOCARDITIS;

EID: 33750827233     PISSN: 15297535     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.PCC.0000244337.52057.7D     Document Type: Conference Paper

References (25)

1. Drucker NA, Colan SD, Lewis AB, et al: γ-Globulin treatment of acute myocarditis in the pediatric population. Circulation 1994; 89:252-257
2. Camargo PR, Snitcowsky R, da Luz PL, et al: Favorable effects of immunosuppressive therapy in children with dilated cardiomyopathy and active myocarditis. Pediatr Cardiol 1995; 16:61-68
3. Kleinert S, Weintraub RG, Wilkinson JL, et al: Myocarditis in children with dilated cardiomyopathy: Incidence and outcome after dual therapy immunosuppression. J Heart Lung Transplant 1997; 16:1248-1254
4. Lee KJ, McCrindle BW, Bohn DJ, et al: Clinical outcomes of acute myocarditis in childhood. Heart 1999; 82:226-233
5. Gagliardi GM, Bevilacqua M, Bassano C, et al: Long term follow up of children with myocarditis treated by immunosuppression and of children with dilated cardiomyopathy. Heart 2004; 90:1167-1171
6. Kishimoto C, Shioji K, Kinoshita M, et al: Treatment of acute inflammatory cardiomyopathy with intravenous immunoglobulin ameliorates left ventricular function associated with suppression of inflammatory cytokines and decreased oxidative stress. Int J Cardiol 2003; 91:173-178
7. Feldman AM, McNamara D: Myocarditis. N Engl J Med 2000; 343:1388-1398
8. Liu C, Chen J, Liu K: Immunosuppressive treatment for inflammatory cardiomyopathy meta-analysis of randomized controlled trials. Int Heart J 2005; 46:113-122
9. Robinson JL, Hartling L, Crumley E, et al: A systematic review of intravenous gamma globulin for therapy of acute myocarditis. BMC Cardiovasc Disord 2005; 5:12
10. Parrillo JE, Cunnion RE, Epstein SE, et al: A prospective, randomized, controlled trial of prednisone for dilated cardiomyopathy. N Engl J Med 1989; 321:1061-1068
11. Mason JW, O'Connell JB, Herskowitz A, et al: A clinical trial of immunosuppressive therapy for myocarditis: The Myocarditis Treatment Trial Investigators. N Engl J Med 1995; 333:269-275
12. McNamara DM, Holubkov R, Starling RC, et al: Controlled trial of intravenous immune globulin in recent-onset dilated cardiomyopathy. Circulation 2001; 103:2254-2259
13. Wojnicz R, Nowalany-Kozielska E, Wojciechowska C, et al: Randomized, placebo-controlled study for immunosuppressive treatment of inflammatory dilated cardiomyopathy: Two-year follow-up results. Circulation 2001; 104:39-45
14. Frustaci A, Chimenti C, Calabrese F, et al: Immunosuppressive therapy for active lymphocytic myocarditis virological and immunologic profile of responders versus nonresponders. Circulation 2003; 107:857-863
15. Hia CP, Yip WC, Tai BC, et al: Immunosuppressive therapy in acute myocarditis: An 18 year systematic review. Arch Dis Child 2004; 89:580-584
16. Ahdoot J, Galindo A, Alejos JC, et al: Use of OKT3 for acute myocarditis in infants and children. J Heart Lung Transplant 2000; 19:1118-1121
17. English RF, Janosky JE, Ettedgui JA, et al: Outcomes for children with acute myocarditis. Cardiol Young 2004; 14:488-493
18. Ciszewski A, Bilinnska ZT, Lubiszewska B, et al: Dilated cardiomyopathy in children: Clinical course and prognosis. Pediatr Cardiol 1994; 15:121-126
19. Balaji S, Wiles HB, Sens MA, et al: Immunosuppressive treatment for myocarditis and borderline myocarditis in children with ventricular ectopic rhythm. Br Heart J 1994; 72:354-359
20. Chan KY, Iwahara M, Benson LN, et al: Immunosuppressive therapy in the management of acute myocarditis in children: A clinical trial. J Am Coll Cardiol 1991; 17:458-460
21. Ino T, Okubo M, Akimoto K, et al: Corticosteroid therapy for ventricular tachycardia in children with silent lymphocytic myocarditis. J Pediatr 195; 126:304-308
22. Talwar KK, Goswami KC, Chopra P, et al: Immunosuppressive therapy in inflammatory myocarditis: Long-term follow-up. Int J Cardiol 1992; 34:157-166
23. Adelson DP, Bratton SL, Carney NA, et al: Introduction. Pediatr Crit Care Med 2003; 4(Suppl):S2-S4
24. Hufnagel G, Pankuweit S, Richter A, et al: The European Study of Epidemiology and Treatment of Cardiac Inflammatory Diseases (ESETCID): First epidemiological results. Herz 2000; 25:279-285
25. Maisch B, Hufnagel G, Kolsch S, et al: Treatment of inflammatory dilated cardiomyopathy and (peri)myocarditis with immunosuppression and i.v. immunoglobulins. Herz 2004; 29:624-636